Everence Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,780
| Closed | -$96K | – | 1039 |
|
|
2024
Q3 | $96K | Sell |
12,780
-8,650
| -40% | -$65K | 0.01% | 744 |
|
|
2024
Q2 | $181 | Hold |
21,430
| – | – | 0.01% | 697 |
|
|
2024
Q1 | $217 | Hold |
21,430
| – | – | 0.01% | 689 |
|
|
2023
Q4 | $216K | Hold |
21,430
| – | – | 0.02% | 679 |
|
|
2023
Q3 | $201 | Buy |
21,430
+11,260
| +111% | +$106 | 0.02% | 674 |
|
|
2023
Q2 | $271K | Hold |
10,170
| – | – | 0.02% | 560 |
|
|
2023
Q1 | $237 | Hold |
10,170
| – | – | 0.02% | 622 |
|
|
2022
Q4 | $257 | Hold |
10,170
| – | – | 0.02% | 595 |
|
|
2022
Q3 | $196K | Hold |
10,170
| – | – | 0.02% | 660 |
|
|
2022
Q2 | $259K | Buy |
+10,170
| New | +$259K | 0.02% | 562 |
|